4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-19-000524
Chief Executive Officer sold 1,130 shares at an average $222.12 ($250,999)
- Chief Executive Officer acquired 1,130 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kummeth Charles R. · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-12-23 | Exercise or conversion : show line 1 in the form | +659 | $67.46 | $44,456 | 130,648 | D |
| 2019-12-23 | Sale : show line 2 in the form | −659 | $222.08 | $146,351 | 129,989 | D |
| 2019-12-24 | Exercise or conversion : show line 3 in the form | +471 | $67.46 | $31,774 | 130,460 | D |
| 2019-12-24 | Sale : show line 4 in the form | −471 | $222.18 | $104,648 | 129,989 | D |
| Open-market sales · 1,130 sh · avg $222.12 · $250,999 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-12-23 | Exercise or conversion : show line 5 in the form Stock Options (Right to Buy) | −659 | 38,689 | D |
| 2019-12-24 | Exercise or conversion : show line 6 in the form Stock Options (Right to Buy) | −471 | 38,218 | D |
Loading xslF345X03/edgar.xml…